Detail Antibody Response Following SARS-CoV-2 Vaccination among Patients with Type 2 Diabetes Mellitus: A Systematic Review (Article of Diabetes & Metabolic Syndrome: Clinical Research & Reviews Vol. 16 2022 p. 1-6) Bibliografi Author: Soetedjo, Nanny Natalia Mulyani ; Iryaningrum, Maria Riastuti ; Lawrensia, Sherly ; Permana, Hikmat Topik: COVID-19; SARS-CoV-2; Vaccination; Diabetes mellitus Bahasa: (EN )     Penerbit: Elsevier     Tahun Terbit: 2022     Jenis: Article - diterbitkan di jurnal ilmiah internasional Fulltext: B2. Publikasi.pdf (575.39KB; 4 download) Abstract Background and aim: DM patients' antibody response after the COVID-19 vaccine is still unknown amid the COVID-19 vaccination rollout. This study aimed to explore the SARS CoV-2 antibody response or seropositivity among DM patients following the COVID-19 vaccine administration. Methods: We performed a systematic review of the literature consisting of observational or crosssectional studies, which reported the antibody serology or seropositivity among DM patients by following the PRISMA 2020 guidelines. Results: Eight studies with a total of 64468 patients were identi?ed, and 5156 (7.9%) of them had diabetes. Most studies showed that antibody response and seropositivity in DM patients were lower than healthy population after one until four weeks following full COVID-19 vaccination dose. Conclusion: The antibody response and seropositivity after the COVID-19 vaccine in DM patients were lower than in healthy subjects. Therefore, DM patients are expected to receive vaccines according to the dose and schedule appropriately and might be prioritized to receive vaccine boosters. Opini Anda Klik untuk menuliskan opini Anda tentang koleksi ini! Lihat Sejarah Pengadaan  Konversi Metadata   Kembali

Copyright © 2006, 2007 Unika Atma Jaya, all rights reserved